Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Earnings Data
Report Date
Apr 30, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.38Last Year’s EPS
0.33Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a generally positive operational and financial picture: strong adjusted EBITDA (Q4 $66M; FY $276M), improved pricing and same-unit growth, a healthy balance sheet (cash $375M; net leverage <1x), AR improvements, and new physician alignment programs. Offsetting items include a $26M revenue headwind from portfolio restructuring, patient volume declines (≈3%), a Q4 operating cash flow decline ($115M vs $135M), and uncertainty around the potential lapse of ACA subsidy effects on payer mix. Management provided a 2026 adjusted EBITDA target modestly above 2025 (midpoint ≈+5%) while guiding revenue flat at ~$1.9B and expecting smaller share repurchases; M&A is not assumed in the outlook. On balance, the positive financial results, strong liquidity, and clear strategic initiatives outweigh the headwinds and uncertainties discussed.Company Guidance
Strong Adjusted EBITDA and Record Full Year
Q4 adjusted EBITDA of $66,000,000 (in line with upward guidance); full-year 2025 adjusted EBITDA of $276,000,000 (record practice bonuses noted). 2026 adjusted EBITDA guidance of $280,000,000 to $300,000,000 (midpoint ~5% above 2025).
Solid Same-Unit Pricing and Same-Unit Growth
Same-unit revenue grew ~4% year-over-year with same-unit pricing up just under 7%, driven by improved RCM cash collections, favorable payer mix, increased acuity (notably in neonatology), and higher contract administrative fees.
Healthy Balance Sheet and Liquidity
Ended quarter with $375,000,000 in cash and net debt just over $220,000,000, implying net leverage just under 1x. The company generated $115,000,000 in operating cash flow in Q4 and remains well-capitalized for investment.
Share Repurchase and Capital Deployment
Deployed $64,000,000 in the quarter to repurchase 2,900,000 shares, leaving ~83,000,000 shares outstanding. Company expects to remain opportunistic on buybacks, but guidance assumes a smaller repurchase program in 2026.
Physician Alignment and Talent Initiatives
Introduced multi-year stock price tracking element for physician cash bonuses (500+ physicians participating) and launched 'Pediatrix Partners' with 46 physician leaders receiving stock tracking grants to support quality, hospital relations, recruiting, retention and growth.
Improved AR and Cash Collections
Accounts receivable DSO improved to 42.8 days at year-end (down almost five days year-over-year), reflecting better cash collections after revenue cycle management transition efforts.
Clear Strategic Growth Opportunities
Management highlighted organic and capability-driven growth opportunities including telemedicine expansion, additional NICU and maternal-fetal medicine capacity, and scaling OB hospital medicine leveraging existing NICU/hospital relationships.
MD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 19, 2026 | $21.97 | $19.30 | -12.15% |
Sep 30, 2025 | $16.22 | $16.75 | +3.27% |
Jun 30, 2025 | $14.03 | $14.35 | +2.28% |
May 06, 2025 | $12.95 | $14.48 | +11.81% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pediatrix Medical Group (MD) report earnings?
Pediatrix Medical Group (MD) is schdueled to report earning on Apr 30, 2026, Before Open (Confirmed).
What is Pediatrix Medical Group (MD) earnings time?
Pediatrix Medical Group (MD) earnings time is at Apr 30, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MD EPS forecast?
MD EPS forecast for the fiscal quarter 2026 (Q1) is 0.38.